ANTICOAGULANT medication Dabigatran Etexilate Capsules USP 75mg and 150mg are not registered in Malaysia, says Health Director-General Dr Noor Hisham Abdullah.
He said the Health Ministry (MOH) had checked the registered products database of the National Pharmaceutical Regulatory Agency (NPRA) to confirm the matter following an article published on the medscape.com website titled ‘Dabigatran Recalled Over Potential Carcinogen’ on March 23.